Le Lézard
Classified in: Oil industry, Science and technology, Business
Subject: CON

McDermott Reaches Mechanical Completion on Pioneering Biosurfactants Project


HOUSTON, March 28, 2024 /PRNewswire/ -- McDermott today announced mechanical completion of a pioneering industrial-scale biosurfactant plant for Evonik. Less than two years from contract award, Evonik has achieved initial production of Rhamnolipids, a bacterial surfactant with the potential to fundamentally transform cleaning products and significantly reduce their environmental impact.

The project positions Evonik, a specialty chemicals company, as a pioneer of high-quality, sustainable biosurfactants on a commercial scale.

The scope of the contract included engineering, procurement, and construction management (EPCM) services for a new biosurfactant plant. The engineering and procurement services were executed from McDermott's office in Brno, Czech Republic, and the construction management was performed at Evonik's site in Slovakia. 

"This is an incredible achievement, completed in a short space of time, thanks to the enduring commitment of our team and their seamless collaboration with Evonik," said Rob Shaul, McDermott's Senior Vice President, Low Carbon Solutions. "The high-performance Rhamnolipids significantly advance the growing biosurfactant market and are setting a precedent as part of a broader sustainable chemicals revolution, bringing sustainable cleaning and personal care products to market faster."

McDermott was selected to partner with Evonik on the pioneering biosurfactants project in 2021.

About McDermott 
McDermott is a premier, fully-integrated provider of engineering and construction solutions to the energy industry. Our customers trust our technology-driven approach engineered to responsibly harness and transform global energy resources into the products the world needs. From concept to commissioning, McDermott's innovative expertise and capabilities advance the next generation of global energy infrastructure?empowering a brighter, more sustainable future for us all. Operating in over 54 countries, McDermott's locally-focused and globally-integrated resources include more than 30,000 employees, a diversified fleet of specialty marine construction vessels and fabrication facilities around the world. To learn more, visit www.mcdermott.com.

Contacts:

Global Media Relations
Reba Reid
Senior Director, Global Communications and Marketing
+1 281 588 5636 
[email protected]

Local Media Relations
Barbara Knight
Senior Director, Area Communications and Marketing
+971 56 403 2903
[email protected]

(PRNewsfoto/McDermott International, Inc.)

 

SOURCE McDermott International, Ltd


These press releases may also interest you

at 00:45
Claudio Bono, Managing Director for two independent Hotels in Silicon Valley, is thrilled to unveil a groundbreaking platform and an idea that will transform the landscape of the urgent unhoused crisis and social issues. Leveraging his extensive...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

26 avr 2024
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...



News published on and distributed by: